Last reviewed · How we verify
ipratropium bromide 0.03% spray — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
ipratropium bromide 0.03% spray (ipratropium bromide 0.03% spray) — Centre for Addiction and Mental Health.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| ipratropium bromide 0.03% spray TARGET | ipratropium bromide 0.03% spray | Centre for Addiction and Mental Health | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- ipratropium bromide 0.03% spray CI watch — RSS
- ipratropium bromide 0.03% spray CI watch — Atom
- ipratropium bromide 0.03% spray CI watch — JSON
- ipratropium bromide 0.03% spray alone — RSS
Cite this brief
Drug Landscape (2026). ipratropium bromide 0.03% spray — Competitive Intelligence Brief. https://druglandscape.com/ci/ipratropium-bromide-0-03-spray. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab